OptiBiotix Health’s (OPTI) “Corporate” Rating Reiterated at FinnCap
OptiBiotix Health (LON OPTI) traded down GBX 1.50 ($0.02) during mid-day trading on Tuesday, hitting GBX 64.50 ($0.87). The stock had a trading volume of 104,714 shares, compared to its average volume of 175,032. OptiBiotix Health has a 52 week low of GBX 59 ($0.79) and a 52 week high of GBX 90 ($1.21).
OptiBiotix Health Company Profile
Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.